The data presents key figures on U.S. public biotech companies from 2012 to 2016. In 2016, U.S. public biotech companies generated some 112 billion USD of revenue in total. In the same year, research and development spending came to nearly 39 billion dollars.
Revenues (in billion US$) | 63.7 | 72.1 | 93 | 107.4 | 112.2 |
R&D expenses (in billion US$) | 19.4 | 23.6 | 28.8 | 34 | 38.8 |
Net income (in billion US$) | 4.4 | 2.7 | 10.6 | 15.3 | 9.2 |
Market capitalization (in billion US$) | 361.3 | 636.5 | 854.6 | 891.2 | 698.6 |
Number of employees | 99910 | 99850 | 109450 | 130100 | 135750 |